Stanton Glantz, PhD's blog

Implementation of tobacco graphic warning labels in India: the interplay between the cigarette and the bidi industries

Sujatha Sankaran, Heikki Hiilamo, and I just published "Implementation of graphic health warning labels on tobacco products in India: the interplay between the cigarette and the bidi industries" in Tobacco Control.
 
Here is the abstract: 
 
Objectives To understand the competition between and among tobacco companies and health groups that led to graphical health warning labels (GHWL) on all tobacco products in India.
  Read more »

Another innovative public health ad from Lorillard/Blu promoting cessation for the seriously addicted smoker trying to quit

Check it out at http://www.youtube.com/watch?v=QZRMumYtYFM
 
This is, of course, part of Lorillard/Blu's ongoing advertising campaign promoting harm reduction; for earlier efforts, click here.

129 public health and medical authorities from 31 countries write WHO DG Chan urging evidence-based approach to ecigs

The following letter, signed by 129 public health and medical experts from 31 countries, representing every WHO region,  was delivered to WHO Director General Margaret Chan earlier today.  (PDF of letter)
 
I also submitted the letter to the FDA dockett on e-cigs; the tracking number is 1jy-8cp3-dzmg. Read more »

122 public health and medical authorities from 31 countries write WHO DG Chan urging evidence-based approach to ecigs

The following letter, signed by 122 public health and medical experts from 31 countries, representing every WHO region,  was delivered to WHO Director General Margaret Chan earlier today.  (PDF of letter)
 
An updated version of the letter, with 129 signatures, is here.
  Read more »

FDA Should Not Extend the Compliance Period for Marketing Applications and Other Submissions

Lauren Lempert and I just submitted this public comment to FDA.  The comment number is 1jy-8cos-3k4o.
 
FDA Should Not Extend the Compliance Period for Marketing Applications and Other Submissions
 
Docket No. FDA-2014-N-0189
 
Lauren K. Lempert, JD, MPH and Stanton A. Glantz, PhD Read more »

FDA should not assume a "continuum of risk" until there is proof that it exists for ecigs as they are actually used

FDA SHOULD NOT MAKE REGULATORY DECISIONS BASED ON THE "CONTINUUM OF RISK" THEORY UNTIL IT HAS AFFIRMATIVE EVIDENCE THAT, AS ACTUALLY USED, E-CIGARETTES OR OTHER TOBACCO PRODUCTS LOWER POPULATION RISK
 
Stanton A. Glantz, PhD
Professor of Medicine
University of California, San Francisco
 
Docket No. FDA-2014-N-0189
  Read more »

FDA Should Restrict Internet Sales of All Tobacco Products Including E-Cigarettes

Stanford Professor Bonnie Halpern-Felsher just submitted this comment to FDA.  The tracking number is 1jy-8cnr-xpv8.
     Read more »

92,000 current smokers in Ontario aged 12-17 were recruited to smoking because of watching smoking in movies

The Ontario Tobacco Research Unit in Canada recently published "Exposure to Onscreen Tobacco in Movies among Ontario Youth, 2004-2013".  Here is the executive summary:
  Read more »

Smoking in top-grossing US movies: 2013

Jono Polansky, Kori Titus, Natalie Lanning and I just released our report "Smoking in top-grossing US movies: 2013."
 
The full report is available at www.escholarship.org/uc/item/1n74f4x1
 
 
SUMMARY of FINDINGS
 
• Exposure to on-screen smoking will recruit 6.4 million smokers from among today’s children. Two million of those recruited to smoke by films will die prematurely from tobacco-induced diseases.
  Read more »

FDA’s Proposed Warning on Addiction is Inadequate and Do Not Reflect Current Understanding of Appropriate Messaging on Addiction

We just submitted this comment to FDA.  The tracking number is 1jy-8cmm-zjhq
 
The FDA’s Proposed Warnings on Addiction are Inadequate and Do Not Reflect Current Understanding of Appropriate Messaging on Addiction
 
Docket No. FDA-2014-N-0189 Read more »

Syndicate content